Observational, bi-directional (prospective and retrospective) study for patients with newly diagnosed ovarian cancer stages IA to IVB, or persistent or recurrent disease from January 2021; irrespective of histology

Trial Identifier:	D133HR00051
Sponsor:	AstraZeneca
Start Date:	September 2025
Primary Completion Date:	March 2026
Study Completion Date:	March 2026
Condition:	Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil	Porto Alegre, Brazil

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.